Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration
- PMID: 9372330
- DOI: 10.2169/internalmedicine.36.700
Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration
Abstract
A 40-year-old male, with a past history of hypertension but receiving no medical treatment, was referred. He manifested malignant hypertension (190/130 mmHg; Keith-Wagener III), renal dysfunction (serum creatinine, 3.8 mg/dl), and elevated plasma aldosterone (450 pg/ml) and active renin concentration (ARC, 104 pg/ml). His blood pressure was controlled with multiple antihypertensive agents and ARC thus decreased (4.3 pg/ml), but aldosterone remained elevated. Abdominal magnetic resonance imaging (MRI) revealed a right adrenal adenoma, and aldosterone-producing adenoma was confirmed by adrenal venous sampling. Primary aldosteronism very rarely develops to malignant hypertension, and even in that case ARC is suppressed. Therefore this is a rare case of primary aldosteronism complicated with malignant hypertension and high ARC.
Comment in
-
Renin/angiotensin/aldosterone system in malignant hypertension.Intern Med. 1997 Oct;36(10):669-71. doi: 10.2169/internalmedicine.36.669. Intern Med. 1997. PMID: 9372322 No abstract available.
Similar articles
-
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.Endocrine. 2003 Aug;21(3):221-6. doi: 10.1385/ENDO:21:3:221. Endocrine. 2003. PMID: 14515005 Review.
-
Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.J Urol. 1995 Jun;153(6):1775-80. doi: 10.1016/s0022-5347(01)67303-8. J Urol. 1995. PMID: 7752314
-
Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.Can J Cardiol. 1999 Mar;15(3):347-8. Can J Cardiol. 1999. PMID: 10202199
-
[Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009].Dtsch Med Wochenschr. 2009 Jul;134(31-32):1582. doi: 10.1055/s-0028-1082830. Epub 2009 Jul 23. Dtsch Med Wochenschr. 2009. PMID: 19629922 German.
-
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.Semin Nephrol. 2013 May;33(3):265-76. doi: 10.1016/j.semnephrol.2013.04.007. Semin Nephrol. 2013. PMID: 23953804 Free PMC article. Review.
Cited by
-
Management of hypertension emergencies.Curr Hypertens Rep. 2003 Dec;5(6):486-92. doi: 10.1007/s11906-003-0056-3. Curr Hypertens Rep. 2003. PMID: 14594569 Review.
-
Malignant Hypertension and Bilateral Primary Aldosteronism.Intern Med. 2023 Sep 15;62(18):2675-2680. doi: 10.2169/internalmedicine.1098-22. Epub 2023 Feb 1. Intern Med. 2023. PMID: 36725041 Free PMC article.
-
Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism.J Biomed Biotechnol. 2011;2011:209787. doi: 10.1155/2011/209787. Epub 2011 Apr 7. J Biomed Biotechnol. 2011. PMID: 21541242 Free PMC article.
-
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.Endocrine. 2003 Aug;21(3):221-6. doi: 10.1385/ENDO:21:3:221. Endocrine. 2003. PMID: 14515005 Review.
-
Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.Intern Med. 2019 Nov 1;58(21):3107-3111. doi: 10.2169/internalmedicine.2327-18. Epub 2019 Jul 10. Intern Med. 2019. PMID: 31292373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous